HCV NS3/4A Protease Substrate - 1 mg
- Cat.Number : AS-60798
- Manufacturer Ref. :
-
Availability :
In stock
A highly sensitive FRET substrate for assaying HCV (Hepatitis C Virus) NS3/4A protease activity. It detects < 0.1pmol of HCV NS3/4A protease. Upon cleavage of this substrate, fluorescence can be monitored at Abs/Em = 490/512 nm.
Specifications
Chemistry | |
Sequence one letter code |
|
---|---|
Sequence three letter code |
|
Molecular Mass/ Weight |
|
Modification | |
Conjugation |
|
Quantity & Purity | |
Purity |
|
Storage & stability | |
Form |
|
Storage Conditions |
|
Activity | |
Application | |
Biomarker Target | |
Research Area | |
Sub-category Research Area | |
Usage |
|
Source | |
Source / Species |
|
Codes | |
Code Nacres |
|
Downloads
You may also be interested in the following product(s)
Citations
Identification of hepatitis C virus inhibitors targeting different aspects of infection using a cell-based assay.
Antimicrob Agents Chemother . 2012 Sep 04 ; 56(12) 6109 | DOI : 10.1128/AAC.01413-12
- X. Yu
- et al
Development of a cell-based hepatitis C virus (HCV) infection FRET assay for high throughput antiviral compound screening.
Antimicrob Agents Chemo . 2009 Jul 20 ; 53(10) 4311 | DOI : 10.1128/AAC.00495-09.
- X. Yu
- et al
Preclinical Characteristics of the Hepatitis C Virus NS3/4A Protease Inhibitor ITMN-191 (R7227).
Antimicrob Agents Chemother . 2008 Sep 29 ; 52(12) 4432 | DOI : 10.1128/AAC.00699-08
- S. Seiwert
- et al
Biliverdin and Heme Oxygenase Antibiral Activity Against Hepatitis C Virus.
Ann Hepatol . 2011 Jan 01 ; 10(1) 105 | DOI : PMID: 21301021
- Y. Gutierrez-Grobe
- et al